scholarly journals A randomized, double-blind, placebo-controlled, cross-over study to evaluate analgesic activity of Terminalia chebula in healthy human volunteers using a mechanical pain model

2016 ◽  
Vol 32 (3) ◽  
pp. 329 ◽  
Author(s):  
Usharani Pingali ◽  
VenkataKishan Pokuri ◽  
ChiranjeeviUday Kumar
2020 ◽  
Vol 237 (10) ◽  
pp. 3097-3107
Author(s):  
Emmanuelle A. D. Schindler ◽  
Ashley M. Schnakenberg Martin ◽  
R. Andrew Sewell ◽  
Mohini Ranganathan ◽  
Anna DeForest ◽  
...  

Pain ◽  
2006 ◽  
Vol 122 (1) ◽  
pp. 81-89 ◽  
Author(s):  
Panos Barlas ◽  
Sharlene L.H. Ting ◽  
Linda S. Chesterton ◽  
Peter W. Jones ◽  
Julius Sim

1996 ◽  
Vol 59 (7) ◽  
pp. 723-726 ◽  
Author(s):  
LEO P. M. LANGEVELD ◽  
WILLEM A. VAN SPRONSEN ◽  
EMERENTIA C. H. VAN BERESTEIJN ◽  
SERVÉ H. W. NOTERMANS

A double-blind experiment with 34 healthy human volunteers, aged between 20 and 60 years, was conducted to obtain information about the allowable concentration of B. cereus in pasteurized milk. During a period of 3 weeks the subjects were exposed to B. cereus naturally present in pasteurized milk following storage for 3 to 14 days at 7.5°C. Of 259 milk exposures, gastrointestinal complaints were observed in 18 cases. According to total numbers of B. cereus ingested per exposure the complaints per number of exposures were distributed as follows: < 106: 5 in 132; 106 to 107: 2 in 32; 107 to 108 : 2 in 26; and > 108: 9 in 69. Symptoms, however, were not typical of those caused by B. cereus. There was a weak significance (P ≤ 0.1) for symptoms when > 108 B. cereus cells were ingested. Milk with 106 to 107 B. cereus cells per ml showed a very low diarrheal enterotoxin titer. Pure cultures of B. cereus strains isolated from samples with high B. cereus concentrations also showed a low production of enterotoxin. It can be concluded that for healthy adults the probability of become diseased from cold-stored pasteurized milk is small. From the results no evidence is obtained that B. cereus concentrations less than 105/ml will cause intoxication.


2010 ◽  
Vol 1 (4) ◽  
pp. 205-210 ◽  
Author(s):  
M. Dusch ◽  
B. Namer ◽  
M. Strupf ◽  
M. Schley ◽  
R. Rukwied ◽  
...  

AbstractBackgroundAnewexperimental protocol of electrically induced pain and hyperalgesia was established to examine orally administered drugs. In a randomized, double-blind, placebo-controlled cross-over study this experimental protocol was used to assess the effects of paracetamol.MethodsTwenty-four subjects were enrolled in this study. The magnitude of pain, axon reflex flare, and areas of pin-prick hyperalgesia and touch-evoked allodynia were assessed in two consecutive sessions; prior to, and 2 h after drug administration. This protocol was repeated after 1 week. Subjects were randomized to receive either paracetamol (2 g) or a placebo.ResultsIn comparison to the placebo arm there were no significant effects of paracetamol on pain, hyperalgesia, allodynia, or axon reflex flare. Pain and flare responses were highly reproducible on the same day (r = 0.77 and r = 0.79, respectively), and after 1 week (r = 0.6 and r = 0.71, respectively). The correlation between areas of hyperalgesia and allodynia was, however, significantly improved when the protocol was repeated on the same day (r = 0.8 and r = 0.75), as opposed to after a week (r = 0.54 and r = 0.53).DiscussionThe electrical pain model is a well established method for the assessment of intravenously applied analgesics. In order to assess effects of orally applied drugs the model had to be modified: for the assessment of hyperalgesia and allodynia a protocol repeating the model within 1 day proved to have advantages over repetition after 1 week.


Sign in / Sign up

Export Citation Format

Share Document